Eni




Eni S.p.A. (Italian pronunciation: [ˈɛːni]) is an Italian multinational oil and gas company headquartered in Rome. Considered one of the global supermajors, it has operations in 79 countries and is currently world's 11th largest industrial company with a market capitalization of 68 billion euros (as of 2020). The Italian government owns a 30.303% golden share in the company, 4.34% held through the state treasury and 25.964% through the Cassa Depositi e Prestiti. The company is a component of the Euro Stoxx 50 stock market index.
History
The company was founded in 1953 as Ente Nazionale Idrocarburi (ENI) to integrate the Italian oil and natural gas sectors. Its founder, Enrico Mattei, played a key role in its development, promoting the idea of negotiating substantial oil concessions in the Middle East and Africa, a policy that led to Italy becoming a significant player in the global oil market. Mattei's mysterious death in a plane crash in 1962 has led to numerous theories about the cause, including assassination due to his progressive oil policies.
Operations
Eni's core business areas include petroleum exploration and production, natural gas exploration and production, petrochemicals, and power generation. It is also involved in the refining and marketing of petroleum products, the production of chemicals, and research and development. The company operates the world's northernmost offshore oil field, located in the Barents Sea.
Exploration and Production
Eni has significant exploration and production activities in countries including Italy, Libya, Egypt, Norway, the UK, Angola, Congo, and the Gulf of Mexico. It has made significant natural gas discoveries, particularly in the Eastern Mediterranean.
Refining and Marketing
The company owns or has interests in several refineries in Italy and abroad, ensuring a significant capacity to process crude oil. Eni sells gasoline and other products through a network of over 6,000 service stations across Europe, Africa, and Asia.
Sustainability
Eni is committed to achieving net-zero emissions in its production processes by 2050. The company has invested in various renewable energy projects, including solar, wind, and biomass, as part of its strategy to transition towards a more sustainable energy future.
Controversies
Eni has been involved in several controversies, including allegations of corruption in international oil deals. The company has faced legal actions and fines related to these allegations, but it has consistently denied any wrongdoing.
See Also
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
